NetScientific and EMV Capital have completed their merger to assemble a portfolio of 15 companies in healthcare, energy and industrial tech.
UK-based commercialisation firm NetScientific completed its all-share acquisition of investment firm EMV Capital yesterday.
The move was first announced earlier this month and was seemingly confirmed without complications.
NetScientific also completed a share issue of around £2.3m ($3m), made up of over 3.5 million shares originally priced at $0.86.
EMV Capital’s managing director Ilian Iliev was appointed chief executive NetScientific in May 2020.
The merged entity now has 15 portfolio companies focused on healthcare, energy and industrial tech across the US, UK and Israel.
The firm expects to exploit transatlantic and international relationships to drive overseas growth for both UK-based and international portfolio companies.
Iliev said: “This transaction expands the combined NetScientific commercialisation and portfolio management group.
“We are very well positioned to address the emerging post-Covid opportunities in healthcare and broader technology sectors.
“The combination of EMV Capital’s specialist capability for syndicating deals between financial and corporate investors with NetScientific’s balance sheet investment and management provides the basis for increased growth.”
